Mike Polark
Stock Analyst at Wolfe Research
(3.35)
# 998
Out of 4,969 analysts
75
Total ratings
50%
Success rate
4.59%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Upgrades: Peer Perform | n/a | $92.25 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $19.68 | +1.63% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $56.58 | +6.04% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $343.53 | +1.88% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $85.60 | +175.70% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $176.59 | -15.06% | 8 | May 2, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $16.99 | +70.69% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $81.22 | -26.13% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $269.21 | -33.14% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $105.04 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $388.56 | +4.23% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $441.18 | +14.01% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $132.18 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $126.05 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $78.92 | +53.32% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $12.35 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $15.98 | +56.45% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $136.77 | +20.64% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $107.53 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.36 | +38.96% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $5.81 | +261.45% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $242.46 | +3.11% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.40 | +2,971.43% | 1 | Sep 2, 2020 |
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $92.25
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $19.68
Upside: +1.63%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $56.58
Upside: +6.04%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $343.53
Upside: +1.88%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $85.60
Upside: +175.70%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $176.59
Upside: -15.06%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $16.99
Upside: +70.69%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $81.22
Upside: -26.13%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $269.21
Upside: -33.14%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $105.04
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $388.56
Upside: +4.23%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $441.18
Upside: +14.01%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $132.18
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $126.05
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $78.92
Upside: +53.32%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $12.35
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $15.98
Upside: +56.45%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $136.77
Upside: +20.64%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $107.53
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $9.36
Upside: +38.96%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $5.81
Upside: +261.45%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $242.46
Upside: +3.11%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.40
Upside: +2,971.43%